In our study, the anti-tumor property of fenofibrate was accompanied by an inhibition of PI3K/AKT/Twist signaling and EMT progression, which was also observed in fenofibrate treated renal transplant model (Wang et al. 2019). Here, AKT1 is linked to neoplasm.